Literature DB >> 18397537

Nasal dryness discomfort in individuals receiving dry oxygen via nasal cannula.

Kenji Miyamoto, Masaharu Nishimura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18397537

Source DB:  PubMed          Journal:  Respir Care        ISSN： 0020-1324            Impact factor:   2.258


× No keyword cloud information.
  6 in total

Review 1.  Rhinitis sicca, dry nose and atrophic rhinitis: a review of the literature.

Authors:  Tanja Hildenbrand; Rainer K Weber; Detlef Brehmer
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-09-29       Impact factor: 2.503

2.  Humidification during oxygen therapy and non-invasive ventilation: do we need some and how much?

Authors:  Jean-Damien Ricard; Alexandre Boyer
Journal:  Intensive Care Med       Date:  2009-03-18       Impact factor: 17.440

3.  Impact of an Improvised System on Preserving Oxygen Supplies in Patients With COVID-19.

Authors:  William Poncin; Lia Baudet; Gregory Reychler; Frédéric Duprez; Giuseppe Liistro; Leila Belkhir; Lucie Pothen; Halil Yildiz; Jean-Cyr Yombi; Julien De Greef
Journal:  Arch Bronconeumol       Date:  2020-08-27       Impact factor: 4.872

4.  Combined high flow nasal cannula and negative pressure ventilation as a novel respiratory approach in a patient with acute respiratory failure and limb-girdle muscular dystrophy.

Authors:  Pasquale Imitazione; Anna Annunziata; Maurizia Lanza; Giuseppe Fiorentino
Journal:  Acta Myol       Date:  2021-06-30

5.  Cold bubble humidification of low-flow oxygen does not prevent acute changes in inflammation and oxidative stress at nasal mucosa.

Authors:  Lauriana Alves Santana; Suellen Karoline Moreira Bezerra; Beatriz Mangueira Saraiva-Romanholo; Wellington Pereira Yamaguti; Iolanda de Fátima Lopes Calvo Tibério; Tabata Maruyama Dos Santos; Renato Fraga Righetti
Journal:  Sci Rep       Date:  2021-07-12       Impact factor: 4.379

6.  Epistaxis in hospitalized patients with COVID-19.

Authors:  Valeria Dell'Era; Riccardo Dosdegani; Paolo Aluffi Valletti; Massimiliano Garzaro
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.